RecruitingPhase 2NCT06471556

Efficacy of Methylprednisolone Pulses in Neuroendocrine Celles Hyperplasia of Infancy : An Early Phase Study

Studying Neuroendocrine cell hyperplasia of infancy

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Assistance Publique - Hôpitaux de Paris
Principal Investigator: Nadia NATHAN, LMHC
Assistance Publique - Hôpitaux de Paris
Intervention: IV Methylprednisolone pulses(drug)
Enrollment: 18 enrolled
Eligibility: 12 years · All sexes
Timeline: 2025 – 2029

Study locations (1)

Pediatric Pulmonology Department and Reference centre for rare lung diseases, Paris, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06471556 on ClinicalTrials.gov

← Back to all trials